Navigation Links
Sickle Cell Disease Patients Seek Acute Pain Care Repeatedly
Date:4/6/2010

Researchers find frequent returns to hospital for treatment, at higher rates than expected

TUESDAY, April 6 (HealthDay News) -- People with sickle cell disease often visit hospitals repeatedly in search of treatment, according to new research.

In eight states studied, researchers found that one-third of sickle cell patients who visited the hospital returned within 30 days in search of pain relief. Young people, between the ages of 18 and 30, were especially likely to seek care.

"I think it's not so much a failure of the hospital itself, but a failure of us being able to prevent these complications and being able to treat them," said Dr. George R. Buchanan, a pediatrics professor at University of Texas Southwestern Medical Center, who is familiar with the study findings.

An estimated 70,000 to 100,000 people in the United States have sickle cell disease, an inherited and often-painful condition that causes red blood cells to turn into a sickle shape. Blacks are most vulnerable to the disease, but other races can develop it too.

"The cells are very inflexible and they clog up the blood vessels," Buchanan said. Oxygen fails to get to tissues in the bone, heart and brain, he said, often leading to severe pain -- "like the pain of a heart attack" -- and organ failure.

Stem-cell treatments can cure the disease, but "the problem is it's risky and only a small minority of patients have a donor, usually a brother or sister, whose bone marrow matches theirs," Buchanan said.

The new study, published in the April 7 issue of the Journal of the American Medical Association, aimed to determine how often sickle cell patients seek acute care from hospitals.

Researchers from the Medical College of Wisconsin and the Children's Research Institute at Children's Hospital of Wisconsin analyzed statistics from hospitals in eight states for the years 2005 and 2006. A total of 21,112 sic
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
2. Statins Show Promise Against Sickle Cell
3. Blood stem-cell transplant regimen reverses sickle cell disease in adults
4. Bone Marrow Transplants May Cure Sickle Cell in Adults
5. New approach to sickle-cell disease shows promise in mice
6. Swine Flu Can Batter Kids With Sickle Cell
7. New study finds barriers to pain treatment in children with sickle cell disease
8. Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease
9. Genetic Engineering Raises Hope for Lyme Disease Vaccine
10. Live Online Chats Answer Questions About Vascular Disease
11. HIV Drugs Might Combat Two Other Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... SIGVARIS proved innovative when they ... compression therapy collection designed exclusively for men. Building ... is proud to announce the launch of three additional ... from a unique, extremely fine synthetic fiber, MIDTOWN MICROFIBER ... and thigh-highs offer a tailored look that is perfect ...
(Date:3/4/2015)... March 04, 2015 The Alliance ... leaders for its upcoming fifth annual Advanced Therapies ... France. The event this year will feature five ... 20 of the field’s leading companies and organizations. ... top executives and clinical researchers from the advanced ...
(Date:3/4/2015)... 04, 2015 Jeannie Mai, TV personality, fashion ... graces the cover of the print publication. Mai embraces the ... organic when shopping for clothes and personal care products. In ... about her commitment to an organic diet. She mentions, “Having ... only in gymnastics, but also now as I’m a full ...
(Date:3/4/2015)... Francisco, CA (PRWEB) March 04, 2015 ... solutions have been selected by Chase Brexton Health ... company announced today. , Chase Brexton provides comprehensive ... more than 30,000 patients across seven clinics in ... early adopters of electronic medical records, the organization ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 A new ... showing promise in terms of extending life. Studies ... that this new dieting routine can help extend life ... production clearly has long term benefits, many suffering from ... a quicker substitute is necessary. As an alternative to ...
Breaking Medicine News(10 mins):Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3
... treatment for sickle cell disease developed at the Los ... 3 clinical trials, David I. Meyer, PhD, LA BioMed ... U.S. have begun administering the sickle cell treatment developed ... LA BioMed and licensed to Emmaus Medical, Inc. The ...
... & Science University Knight Cancer Institute researchers found that the ... acts independently of the HER-2 gene, known to be a ... gene could ultimately help fine-tune a patient,s treatment and enable ... The study, published online this month by Breast Cancer ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... airborne fungus that can cause life-threatening illness -- is an ... Thursday. While C. gattii infections are rare ... they can be severe and even fatal, researchers at the ...
... of the Division of Allergy and Immunology at ... to extend funding of his long-standing investigation into ... the award from the National Institute of Allergy ... record of research accomplishment." Eosinophilic disorders ...
... Hepatitis B virus (HBV) and hepatitis C virus (HCV) ... according to a new study in Gastroenterology , ... Institute. In this study, doctors found that anesthesia contamination ... infection. Efforts are needed to better educate ...
... Calif.) A total joint replacement registry based on ... quality of care, cost-effectiveness and research, according to a ... Clinical Orthopedics and Related Research , a journal ... Kaiser Permanente,s Total Joint Replacement Registry the nation,s ...
Cached Medicine News:Health News:Sickle cell treatment developed at LA BioMed enters Phase 3 clinical trial 2Health News:OHSU Knight Cancer Institute researchers isolate importance of gene in breast cancer prognosis 2Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 2Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 3Health News:Doctor at Cincinnati Children's receives prestigious NIH MERIT Award 2Health News:Misuse of anesthesia could cause hepatitis virus transmission 2Health News:Kaiser Permanente demonstrates success of large-scale total joint replacement registry 2
(Date:3/3/2015)... Actavis plc (NYSE: ACT ) today announced ... aggregate principal amount of senior unsecured notes in 10 ... by its indirect wholly-owned subsidiary, Actavis Funding SCS, and ... as follows: Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... , Due 2016 , 100.00% 1.850% Senior ...
(Date:3/3/2015)... 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... hospital acute care and gastroenterology, today announced fourth ... revenue grew 15% in 2014 to $37 million, ... $0.35 per diluted share. At the end of ... million including $55 million in cash and investments, ...
(Date:3/3/2015)... March 3, 2015 /CNW/ - The issue: ... a health product being injected at Art Nails Ltd., located at ... to be unauthorized as it contained no labelling. All products administered ... by Health Canada and must have approved labelling. ... been administered to consumers. Potential risks associated with injecting an unauthorized ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Advisory - Health product seized from Art Nails in Vancouver 2
... Health today announced its board of directors has approved a cash ... join the company,s board of directors. At its ... share, payable on Oct. 15 to shareholders of record on Oct. ... Cardinal Health. The board of directors also announced ...
... YORK, Aug. 3, 2011 FedEx and ORBIS International, ... today kicked off a North American Goodwill Tour in ... $5.375 million commitment in the form of cash and ... an MD-10-30 cargo aircraft to ORBIS to be the ...
Cached Medicine Technology:Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director 2Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director 3FedEx Donates $5 Million and MD-10-30 Aircraft to ORBIS International 2FedEx Donates $5 Million and MD-10-30 Aircraft to ORBIS International 3FedEx Donates $5 Million and MD-10-30 Aircraft to ORBIS International 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: